This inventor holds 1 USPTO granted patent and 10 published patent applications, plus 3 CIPO patents. Top assignee: Rome Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Donna L. Romero: Innovator in Medical Treatments
Introduction
Donna L. Romero is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of medical treatments, particularly in the development of compounds aimed at addressing serious health disorders. Her innovative work has the potential to impact the lives of many individuals suffering from various diseases.
Latest Patents
Donna L. Romero holds 1 patent for her invention titled "Compounds and methods for treating disease." This patent provides compounds, compositions, and methods for treating medical disorders such as cancer, autoimmune disorders, and neurological disorders. The invention focuses on inhibiting LINE1 reverse transcriptase and/or HERV-K reverse transcriptase using a compound according to Formula I or a pharmaceutically acceptable salt thereof, or a related compound provided in her patent.
Career Highlights
Throughout her career, Donna has demonstrated a strong commitment to advancing medical science. Her work at Rome Therapeutics, Inc. has positioned her as a key player in the development of innovative therapies. She has been instrumental in driving research that aims to improve treatment options for patients with complex medical conditions.
Collaborations
Donna collaborates with talented professionals in her field, including Oliver Saunders and Gregory Stuart Bisacchi. These partnerships enhance her research efforts and contribute to the overall success of her projects.
Conclusion
Donna L. Romero is a dedicated inventor whose work in medical treatments showcases her innovative spirit and commitment to improving healthcare. Her contributions are paving the way for new therapeutic options that could benefit countless individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile